The Biology and Diagnosis of AME
At a Glance
AME is suspected when high blood pressure occurs with very low renin and aldosterone, low potassium, and metabolic alkalosis. A high cortisol-to-cortisone ratio suggests 11β-HSD2 dysfunction, but urine testing and HSD11B2 genetics must be interpreted together because licorice or drugs can mimic AME.
Understanding the biology of Apparent Mineralocorticoid Excess (AME) requires looking at how the body processes hormones. While high blood pressure is the most visible symptom, the “engine room” of the problem is in the kidney, where a specific enzyme failure changes how the body handles salt and potassium [1][2].
The Biology of “Apparent” Excess
In a healthy body, the hormone aldosterone signals the kidneys to hold onto salt and release potassium. AME is called “apparent” excess because while the body acts like it has too much aldosterone, the actual levels of aldosterone in the blood are often very low [3].
The culprit is cortisol, your body’s primary stress hormone. Cortisol is very similar in structure to aldosterone. In the kidneys, there is an enzyme called 11β-HSD2 (encoded by the HSD11B2 gene) that acts as a filter [4]. It normally converts active cortisol into inactive cortisone. When this enzyme is missing or broken due to a genetic mutation or chemical exposure, cortisol stimulates the kidney’s receptors, “pretending” to be aldosterone [5][2]. The kidney responds by aggressively reabsorbing sodium (salt) and water while dumping potassium into the urine [6][7].
The Diagnostic Lab Profile
To evaluate AME, doctors look for a specific “signature” in the blood and urine. Because the body is already overwhelmed by the false signal from cortisol, it shuts down its own natural salt-regulating system to compensate [8].
- Suppressed Renin: Renin is an enzyme that starts the process of salt retention. In AME, renin levels drop to nearly zero because the body is already holding onto far too much salt [8][7].
- Low Aldosterone: Unlike other forms of high blood pressure, aldosterone is usually very low or undetectable in AME [2][9].
- Hypokalemia: This is the medical term for low potassium. The kidneys are “leaking” potassium into the urine, which can cause muscle weakness or fatigue [7][10].
- Metabolic Alkalosis: This occurs when the blood becomes too alkaline (high pH) due to the way the kidneys are processing electrolytes [8][10].
The Biochemical Evidence: The Cortisol/Cortisone Ratio
The most definitive biochemical test for 11β-HSD2 deficiency is a urine sample to measure the ratio of cortisol metabolites to cortisone metabolites (like THF+5αTHF/THE). In AME, the amount of free cortisol or its metabolites is abnormally high compared to cortisone metabolites because the conversion process is broken [11][3].
What this test can and cannot tell you: An abnormal ratio shows the enzyme is failing, but it does not definitively prove genetic AME by itself—licorice or certain drugs can also cause this pattern. It also does not mean the body is producing too much total cortisol overall, just that the kidneys are failing to convert it.
Important Note: Laboratory reports can be confusing. Some labs report the cortisol-to-cortisone ratio (which will be high in AME), while others report the cortisone-to-cortisol ratio (which will be low in AME). Always verify which way the ratio is oriented with your specialist [8][11].
Distinguishing AME from Similar Conditions
AME belongs to a group of conditions involving low-renin hypertension. Because many of these look similar, doctors use a differential diagnosis matrix to tell them apart:
| Feature | Classic AME | Liddle Syndrome | Primary Aldosteronism |
|---|---|---|---|
| Renin | Very Low | Very Low | Low |
| Aldosterone | Very Low | Very Low | High |
| Potassium | Low | Low | Low |
| Cortisol Ratio | Abnormal | Normal | Normal |
| Genetic Cause | HSD11B2 mutation | ENaC mutations | Various (e.g., KCNJ5) |
While Liddle Syndrome and AME look nearly identical on basic blood tests (both have low renin and low aldosterone), Liddle is caused by mutations in ENaC genes and only AME shows the abnormal cortisol-to-cortisone ratio [2][10].
Confirming the Diagnosis with Genetic Testing
Genetic testing for the HSD11B2 gene is used to investigate the molecular cause.
- Because AME is autosomal recessive, finding pathogenic variants on both copies of the gene supports classic AME [12].
- However, genetic testing can sometimes yield a Variant of Uncertain Significance (VUS) or fail to find a variant due to technical limitations. A clinical diagnosis evaluates the labs and the genetics together [3][13].
Common Diagnostic Data Points
While not every person must have all tests completed before treatment begins, a full diagnostic workup often includes:
- Plasma Renin Activity (PRA) or Direct Renin Concentration (DRC) (should be suppressed) [8].
- Serum Aldosterone level (should be low) [2].
- Serum Potassium and Bicarbonate (to check for hypokalemic alkalosis) [8].
- Urinary Steroid Profile (specifically the ratio of cortisol metabolites to cortisone metabolites) [3].
- Molecular Genetic Analysis of the HSD11B2 gene [12].
- Kidney Ultrasound (to check for nephrocalcinosis, or calcium deposits) [3].
Common questions in this guide
What blood test pattern is typical of apparent mineralocorticoid excess?
What does the cortisol-to-cortisone urine ratio mean in AME?
Does apparent mineralocorticoid excess mean my body makes too much cortisol?
Can HSD11B2 genetic testing confirm AME?
How is AME different from Liddle syndrome or primary aldosteronism?
What tests are used to investigate AME?
Can licorice or medicines cause an AME-like test result?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Which blood and urine tests would you use to evaluate AME for me?
Genetic testing
Would genetic testing of the HSD11B2 gene help clarify the cause in my case?
Similar conditions
How might my results differ between AME and Liddle syndrome?
Get notified when new evidence is published on Apparent mineralocorticoid excess.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Alterations of Cortisol Metabolism in Human Disorders.
White PC
Hormone research in paediatrics 2018; (89(5)):320-330 doi:10.1159/000485508.
PMID: 29843121 - 2
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics.
Lu YT, Zhang D, Zhang QY, et al.
Journal of translational medicine 2022; (20(1)):500 doi:10.1186/s12967-022-03698-9.
PMID: 36329487 - 3
Apparent mineralocorticoid excess mimicking Bartter syndrome in infancy.
Hatipoğlu S, Yıldırım E, Şalbaş ÖY, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0333.
PMID: 42912472 - 4
The Dehydrogenase Hypothesis.
Woods C, Tomlinson JW
Advances in experimental medicine and biology 2015; (872()):353-80 doi:10.1007/978-1-4939-2895-8_16.
PMID: 26216003 - 5
In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity.
Kley M, Moser SO, Winter DV, Odermatt A
Methods in enzymology 2023; (689()):167-200 doi:10.1016/bs.mie.2023.04.005.
PMID: 37802570 - 6
Renal Dysfunction Induced by Kidney-Specific Gene Deletion of Hsd11b2 as a Primary Cause of Salt-Dependent Hypertension.
Ueda K, Nishimoto M, Hirohama D, et al.
Hypertension (Dallas, Tex. : 1979) 2017; (70(1)):111-118 doi:10.1161/HYPERTENSIONAHA.116.08966.
PMID: 28559392 - 7
Monogenic forms of low-renin hypertension: clinical and molecular insights.
Khandelwal P, Deinum J
Pediatric nephrology (Berlin, Germany) 2022; (37(7)):1495-1509 doi:10.1007/s00467-021-05246-x.
PMID: 34414500 - 8
Apparent mineralocorticoid excess.
Funder JW
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):151-153 doi:10.1016/j.jsbmb.2016.03.010.
PMID: 26956190 - 9
Review of the Pathophysiologic and Clinical Aspects of Hypokalemia in Children and Young Adults: an Update.
Bamgbola OF
Current treatment options in pediatrics 2022; (8(3)):96-114 doi:10.1007/s40746-022-00240-3.
PMID: 37521171 - 10
Liddle syndrome caused by SCNN1B mutation presenting with severe early-onset hypertension and hypokalemia in an adolescent: a case report.
Min X, Liang Y
BMC endocrine disorders 2026; (26(1)).
PMID: 42426704 - 11
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation.
Pizzolo F, Friso S, Morandini F, et al.
The Journal of clinical endocrinology and metabolism 2015; (100(9)):E1234-41 doi:10.1210/jc.2015-1760.
PMID: 26126204 - 12
Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia.
Fan P, Lu YT, Yang KQ, et al.
Endocrine 2020; (70(3)):607-615 doi:10.1007/s12020-020-02460-9.
PMID: 32816205 - 13
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency.
Yau M, Haider S, Khattab A, et al.
Proceedings of the National Academy of Sciences of the United States of America 2017; (114(52)):E11248-E11256 doi:10.1073/pnas.1716621115.
PMID: 29229831
This page explains AME biology and diagnostic testing for informational purposes only; it is not medical advice and cannot diagnose you or your child. Your healthcare team should interpret hormone, urine, and genetic results.